Skip to main content

Table 3 Treatment related adverse events

From: Salvage therapy of pretreated advanced breast cancer with bevacizumab and paclitaxel every two weeks: a retrospective case review study

  No. of patients (n = 42) %
Hypertension (Grade I) 7 16.7
Proteinuria (Grade II) 2 4.8
Febrile neutropenia (Grade III) 1 2.4
Arterial thrombosis (Grade II) 1 2.4
Venous thrombosis (Grade II) 1 2.4
Toxicity related deaths 1 2.4